Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
Impressively broad coverage of cross-border investments, licensing, corporate and compliance matters, especially those relating to the FCPA. Prominent for its core expertise in transactional and regulatory matters, particularly the Shanghai and Hong Kong offices, while the Seoul team is notable for its IP expertise. Experience in handling cross-border licensing and commercialisation agreements. Leverages its capital markets expertise to act on IPOs and other related matters for clients in this industry. Retains a standout client roster of multinational biotech, pharmaceutical and healthcare companies. Leverages the support of US colleagues to advise on inbound and outbound transactions.
The "outstanding" and "incredibly responsive" team is lauded for "providing clear, pragmatic advice based on their extensive knowledge and experience."
Advised Everest Medicines on its USD125 million licensing agreement with Immunomedics.
Arthur Mok, Katherine Wang and Geoffrey Lin are key contacts for clients, all based in the firm's Shanghai office.
This content is provided by Ropes & Gray LLP.
The attorneys and technical specialists who make up our global life sciences group understand the unique needs of a wide range of clients in the dynamic life sciences industry. We work across practices and geographies to develop cutting-edge solutions that help our clients meet their business goals.
To learn more about our practice, please visit: https://www.ropesgray.com/practices/life-sciences.aspx